Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cyclosporine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPIA known ✓ | P62937 | 5/20 | 0.84 |
| ▸ | ABCB1 | P08183 | 13/20 | 0.84 |
| ▸ | FKBP1B | P68106 | 3/20 | 0.84 |
| ▸ | PPP3CA | Q08209 | 2/20 | 0.84 |
| ▸ | MEN1 | O00255 | 1/20 | 0.84 |
| ▸ | NPC1 | O15118 | 1/20 | 0.84 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.84 |
| ▸ | GMNN | O75496 | 1/20 | 0.84 |
| ▸ | USP2 | O75604 | 1/20 | 0.84 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.84 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.84 |
| ▸ | LMNA | P02545 | 1/20 | 0.84 |
| ▸ | POLB | P06746 | 1/20 | 0.84 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.84 |
| ▸ | MAPT | P10636 | 1/20 | 0.84 |
| ▸ | RARB | P10826 | 1/20 | 0.84 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.84 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.84 |
| ▸ | TACR2 | P21452 | 1/20 | 0.84 |
| ▸ | PPIB | P23284 | 1/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclosporine SCHEMBL4533834 | 1.00 | ABCB1 (0.84) | ABCB1PPIAFKBP1BPPP3CAMEN1 | |
| Cyclosporine SCHEMBL1653706 | 0.94 | ABCB1 (0.87) | ABCB1PPIAFKBP1BPPP3CAMEN1 | |
| Cyclosporine SCHEMBL1653705 | 0.94 | ABCB1 (0.87) | ABCB1PPIAFKBP1BPPP3CAMEN1 | |
| SCHEMBL17921916 | 0.93 | ABCB1 (0.93) | ABCB1PPIAFKBP1BPPP3CAMEN1 | |
| SCHEMBL22145472 | 0.93 | ABCB1 (0.93) | ABCB1PPIAFKBP1BPPP3CAMEN1 | |
| Cyclosporine SCHEMBL8713001 | 0.92 | ABCB1 (0.94) | ABCB1PPIAFKBP1BPPP3CAMEN1 | |
| Cyclosporine SCHEMBL8713005 | 0.92 | ABCB1 (0.94) | ABCB1PPIAFKBP1BPPP3CAMEN1 | |
| SCHEMBL23110210 | 0.92 | ABCB1 (1.00) | ABCB1PPIAFKBP1BPPP3CAMEN1 | |
| SCHEMBL23382247 | 0.92 | ABCB1 (1.00) | ABCB1PPIAFKBP1BPPP3CAMEN1 | |
| Cyclosporine SCHEMBL23192320 | 0.92 | ABCB1 (1.00) | ABCB1PPIAFKBP1BPPP3CAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7511013-B2 | Cyclosporin analogues and their pharmaceutical uses | AMR TECHNOLOGY, INC. (US) | 2009-03-31 | — | — | US | disclosed |
| WO-2007112345-A2 | USE OF CYCLOSPORIN ALKENE ANALOGUES FOR PREVENTING OR TREATING VIRAL-INDUCED DISORDERS | AMR TECHNOLOGY, INC. (US) | 2007-10-04 | — | — | WO | disclosed |
| US-20070232532-A1 | Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders | AMR TECHNOLOGY, INC. (US) | 2007-10-04 | — | — | US | disclosed |
| EP-1804823-A2 | NOVEL CYCLOSPORIN ANALOGUES AND THEIR PHARMACEUTICAL USES | AMR Technology, Inc. (US) | 2007-07-11 | — | — | EP | disclosed |
| WO-2006039164-A2 | NOVEL CYCLOSPORIN ANALOGUES AND THEIR PHARMACEUTICAL USES | AMR TECHNOLOGY, INC. (US) | 2006-04-13 | — | — | WO | disclosed |
| US-20060069015-A1 | Novel cyclosporin analogues and their pharmaceutical uses | AMR TECHNOLOGY, INC. (US) | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060069015-A1 | Novel cyclosporin analogues and their pharmaceutical uses | PPP3R1, FCGRT, IL2 | PPIA 902/4885ABCB1 46/4885FKBP1B 10/4885 |
| US-20070232532-A1 | Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders | HAVCR2, MALT1, NFATC1 | PPIA 1026/4885ABCB1 705/4885FKBP1B 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.